Initially, the authors focused on the effect of 2DG on the tyrosine kinase KIT and found that 2DG treatment inhibits KIT and KIT-dependent signaling, including PI3K-AKT, in some GIST cells. Here, AKT1 is linked to gastrointestinal stromal tumor.